Milner Institute celebrates success of 2024 Pitch Day and Therapeutics Symposium
Last week, we were delighted to host two sell-out events in Cambridge that brought academics, investors, pharma and biotech companies together. On 1st July, we hosted our Milner Pitch Day at St Catharine’s College, which aimed to accelerate innovative ideas toward...
Milner welcomes Flagship Pioneering to learn more about the Institute’s unique model
We were delighted to welcome Flagship Pioneering to the Milner Therapeutics Institute this week. Noubar Afeyan and colleagues from Flagship visited the Institute to learn more about the Milner model and discuss how we might work together in future. It was fantastic to...
Milner Director Tony Kouzarides awarded a knighthood in the King’s Birthday Honours List
We are delighted to share that our Director, Professor Sir Tony Kouzarides – a Professor of Cancer Biology at the University of Cambridge and a Senior Group Leader at the Gurdon Institute – has been awarded a knighthood for his services to healthcare innovation and...
Milner collaboration develops organoid assays that could help identify new treatments for Crohn’s disease
Work at the Milner Therapeutics Institute in collaboration with Professor Matthias Zilbauer has made a promising step toward identifying more precise and personalised treatments for patients with Crohn’s disease. The research published today in Gut reports how Milner...